22:59 EST Cathie Wood’s ARK Investment buys 116K shares of Beam Therapeutics (BEAM) today
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Cathie Wood Dumps Over $5M in a Biotech Stock, Buys WeRide and Tempus AI
- Beam Therapeutics: Buy Rating Backed by BEAM-302 Progress, 2026 Data Catalyst, and De-Risked Accelerated Approval Path
- Cathie Wood Buys Netflix and AI Stocks, Dumps Beam, PINS, and GitLab Shares
- Beam Therapeutics: Undervalued Base-Editing Leader with De-Risked BEAM-302 Driving $46 Price Target and Overweight/Buy Rating
- Beam Therapeutics price target raised to $41 from $37 at Bernstein